Načítá se...
When to Initiate Disease-Modifying Drugs for Relapsing Remitting Multiple Sclerosis in Adults?
For patients with Relapsing Remitting Multiple Scierosis Beta Interfaerons and Glatiramer Acetate were the first to be licensed for treatment. This review deals with one major question: when to initiate therapy? Through exploring the unique characteristics of the disease and treatement we suggest an...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Hindawi Publishing Corporation
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3195775/ https://ncbi.nlm.nih.gov/pubmed/22096641 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/724871 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|